Scientific Publications Search Search Author Impact Factor Release Date Research Group Search Sort by RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Order AscDesc Kieback, Elisa Dr. (1) Lorenz, Felix Dr. (1) Obenaus, Matthias (1) Rehm, Armin Dr. (1) Uckert, Wolfgang Prof. Dr. (10) (-) Blankenstein, Thomas Prof. Dr. (2) (-) Höpken, Uta Elisabeth PD Dr. (1) (-) Leisegang, Matthias Dr. (3) 1998 (2) 2000 (2) 2004 (1) 2005 (3) 2006 (2) 2007 (1) 2008 (2) (-) 2009 (1) 2011 (2) 2012 (3) 2014 (2) (-) 2015 (3) 2016 (2) 2017 (2) 2018 (1) 2019 (1) 2021 (1) Biology of Malignant Lymphomas (9) Mathematical Modelling of Cellular Processes (1) Microenvironmental Regulation in Autoimmunity and Cancer (8) (-) Molecular Cell Biology and Gene Therapy (4) Molecular Immunology and Gene Therapy (5) Psychoneuroimmunology (1) Signal Transduction in Tumor Cells (2) Structural Biology of Membrane-Associated Processes (1) Systems Biology of Gene Regulatory Elements (1) 4 Results: Active Filter: Blankenstein, Thomas Prof. Dr.Höpken, Uta Elisabeth PD Dr.Leisegang, Matthias Dr.Molecular Cell Biology and Gene Therapy20092015 Sort: Result score Newest to oldest Oldest to newest June 01, 2015 / BIOspektrum Designer T cells - New possibilities for immunotherapy of cancer [Designer-T-Zellen - neue Möglichkeiten für die Immuntherapie von Krebs] M. Leisegang W. Uckert April 01, 2015 / Curr Opin Immunol Targeting cancer-specific mutations by T cell receptor gene therapy T. Blankenstein M. Leisegang W. Uckert H. Schreiber April 01, 2015 / Nat Biotechnol Identification of human T-cell receptors with optimal affinity to cancer antigens using antigen-negative humanized mice M. Obenaus C. Leitão M. Leisegang X. Chen I. Gavvovidis P. van der Bruggen W. Uckert D.J. Schendel T. Blankenstein August 01, 2009 / J Clin Invest The tumor-associated antigen EBAG9 negatively regulates the cytolytic capacity of mouse CD8+ T cells C. Rueder U.E. Höpken J. Wolf H.W. Mittruecker B. Engels B. Erdmann S. Wollenzin W. Uckert B. Dörken A. Rehm
June 01, 2015 / BIOspektrum Designer T cells - New possibilities for immunotherapy of cancer [Designer-T-Zellen - neue Möglichkeiten für die Immuntherapie von Krebs] M. Leisegang W. Uckert
April 01, 2015 / Curr Opin Immunol Targeting cancer-specific mutations by T cell receptor gene therapy T. Blankenstein M. Leisegang W. Uckert H. Schreiber
April 01, 2015 / Nat Biotechnol Identification of human T-cell receptors with optimal affinity to cancer antigens using antigen-negative humanized mice M. Obenaus C. Leitão M. Leisegang X. Chen I. Gavvovidis P. van der Bruggen W. Uckert D.J. Schendel T. Blankenstein
August 01, 2009 / J Clin Invest The tumor-associated antigen EBAG9 negatively regulates the cytolytic capacity of mouse CD8+ T cells C. Rueder U.E. Höpken J. Wolf H.W. Mittruecker B. Engels B. Erdmann S. Wollenzin W. Uckert B. Dörken A. Rehm
